Subscribe
e.g. organoids

Axicabtagene Ciloleucel in Large B Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation: The Phase II Alycante Trial

Investigators conducted a Phase II study (ALYCANTE) to assess the efficacy and safety of a single axi-cel infusion as a second-line therapy in patients with high-risk relapsed/refractory (R/R) large B cell lymphoma deemed ineligible for ASCT but eligible for CAR-T cell therapy.
[Nature Medicine]
Full Article
Published In
NewslettersCell Therapy NewsHematopoiesis News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

Regulatory T Cells Require IL6 Receptor Alpha Signaling to Control Skeletal Muscle Function and Regeneration

[Cell Metabolism] Using exercise and sarcopenia models, mice lacking IL6Rα on T cells demonstrated deficits in regulatory T cells, their functional maturation, and a more pronounced decline in muscle mass.
Immune Regulation NewsMuscle Cell NewsNewsletters
Read more

Oncometabolite D-2-Hydroxyglutarate—Dependent Metabolic Reprogramming Induces Skeletal Muscle Atrophy during Cancer Cachexia

[Communications Biology] Based on the up-regulation of catabolism and down-regulation of anabolism, researchers showed genetic mutation-mediated metabolic reprogramming in the progression of cancer cachexia by screening for metabolites and investigating their direct effect on muscle atrophy.
Muscle Cell NewsNewsletters
Read more

Myeloid-Derived Growth Factor Suppresses VSMC Dedifferentiation and Attenuates Postinjury Neointimal Formation in Rats by Activating S1PR2 and Its Downstream Signaling

[Acta Pharmacologica Sinica] Researchers investigated the effect of myeloid-derived growth factor to postinjury neointimal formation and the underlying mechanisms. Rat carotid arteries balloon-injured model was established.
Muscle Cell NewsNewsletters
Read more
Brought to you by